BB
About
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 1,530 investors are based in Beijing, Beijing, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Beijing, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Brii
Search Investors